185 related articles for article (PubMed ID: 37089593)
21. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
[TBL] [Abstract][Full Text] [Related]
22. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
23. Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.
Fujiwara M; Morales AV; Seo K; Kim YH; Arber DA; Sundram UN
Am J Dermatopathol; 2013 Feb; 35(1):11-8. PubMed ID: 22588547
[TBL] [Abstract][Full Text] [Related]
24. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
[TBL] [Abstract][Full Text] [Related]
27. Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumour.
Tadmor T; Liphshitz I; Aviv A; Landgren O; Barchana M; Polliack A
Br J Haematol; 2012 May; 157(4):457-62. PubMed ID: 22390778
[TBL] [Abstract][Full Text] [Related]
28. Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma.
Lang CCV; Ramelyte E; Dummer R
Front Oncol; 2020; 10():1163. PubMed ID: 32850331
[No Abstract] [Full Text] [Related]
29. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries.
Koljonen V; Rantanen M; Sahi H; Mellemkjær L; Hansen BT; Chen T; Hemminki K; Pukkala E
Leuk Lymphoma; 2015; 56(12):3315-9. PubMed ID: 25899400
[TBL] [Abstract][Full Text] [Related]
30. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
Beroukhim K; Pourang A; Eisen DB
J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886
[TBL] [Abstract][Full Text] [Related]
31. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
32. Odds of Merkel cell carcinoma metastases associated with primary anatomic site and laterality.
Ghanian S; Rhee J; Cho E; Walker J
Arch Dermatol Res; 2021 Dec; 313(10):873-877. PubMed ID: 33599821
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma.
Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967
[TBL] [Abstract][Full Text] [Related]
34. The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Feuerman H; Snast I; Amitay-Laish I; Bairey O; Barzilai A; Feinmesser M; Mimouni D; Even-Sapir E; Hodak E
Isr Med Assoc J; 2019 Sep; 21(9):580-584. PubMed ID: 31542900
[TBL] [Abstract][Full Text] [Related]
35. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
36. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma.
Cretella P; Peluso AL; Picariello C; Cozzolino I; Triggiani M; Puzziello A; Giudice V; Sabbatino F; Ieni A; Zeppa P; Caputo A
Pathol Res Pract; 2022 Mar; 231():153804. PubMed ID: 35183824
[TBL] [Abstract][Full Text] [Related]
38. Second neoplasms in patients with Merkel cell carcinoma.
Brenner B; Sulkes A; Rakowsky E; Feinmesser M; Yukelson A; Bar-Haim E; Katz A; Idelevich E; Neuman A; Barhana M; Fenig E
Cancer; 2001 Apr; 91(7):1358-62. PubMed ID: 11283937
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
40. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
